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rating the videolaparoscopy technique into SUS. Survey about the number of hos-
pitalization and expenditures related to bariatric surgeries effectuated in Brazil in
the period between 2008 and 2012. METHODS: Search, analysis and critical scien-
tific literature usage based on Medline, Pesquisa Saúde and Rebrats (The Brazilian
Network for Health Technology Assessment). A priority was attributed to Brazilian
studies and studies financed by Department of Science and Technology (DECIT) of
the Ministry of Health of Brazil. Data acquisition of expenditures related to bariatric
surgery in the database of the IT Department of SUS (DATASUS). RESULTS: There
have been no observable differences between laparotomical and laparoscopical
methods in such terms as mortality and weight loss. But there have been signifi-
cant differences in the quality of life of the patient and internalization time. The
studies financed by DECIT show that the cost of the surgery varies according to the
access route. The average expenditure for videolaparoscopy was US$12,448.00
compared to US$4,911.00 for the conventional surgery. Data of DATASUS indicates
that the number of hospitalization for bariatric surgery paid by SUS was 16.785. In
this period an increase of more than 68% was observed. The aggregate value of the
expenditure in this field was US$44,116,330.031 for these years. CONCLUSIONS:
The results show that the number of bariatric surgery has increased significantly in
the last years. Therefore it’s necessary to conduct a cost-benefit analysis in the
standpoint of the SUS. This analysis should consider the implications to the quality
of live of patients when evaluating videolaparoscopy bariatric surgery way.
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COST-EFFECTIVENESS ANALYSIS OF TREATMENT FOR RECTAL CANCER
FOLLOWING CLINICAL COMPLETE RESPONSE
Rickles AS, Iannuzzi JC, Fleming FJ, Francone TD, Dolan JG, Monson JR, Noyes K
University of Rochester School of Medicine and Dentistry, Rochester, NY, USA
OBJECTIVES: Total mesorectal excision (TME) in combination with neoadjuvant
chemoradiation (CRT) therapy is the mainstay of rectal cancer treatment today.
With the standard implementation of CRT, however, 15-30% of patients will have a
complete response to therapy without any evidence of residual cancer prior to
surgery. Current standard of care remains to be subsequent surgery along with the
associated risks of a stoma and operative morbidity. Some researchers challenge
the current trends and suggest that these patients can be closely observed rather
than undergo surgery. Using decision analysis modeling we sought to determine
the most cost-effective therapy for patients with rectal cancer who have clinical
complete response (cCR): observation, local resection, or TME. METHODS: An ex-
tensive literature review was performed to determine the event rates, utilities and
costs. Expert opinion was used when there were gaps in the literature. Sensitivity
analysis was performed to determine which variables had the largest influence on
treatment decision. RESULTS: A non-operative approach dominated both local
excision and TME for a cost-effective treatment. Observation without surgery pro-
vided 0.16 additional QALYs over a 5-year period when compared to local excision
and was over $3,000 cheaper. Choosing to observe the patient saved nearly $17,000
compared to TME and added an additional 0.96 QALYs over 5 years. On sensitivity
analysis the probability of a local or distant recurrence when choosing to observe
the patient had the largest effect on the outcome, with a threshold of greater than
12% risk of local or distant recurrence changing the preferred decision to perform
local excision. CONCLUSIONS: Rectal cancer patients with clinical complete re-
sponse often undergo unnecessary and costly surgery. This cost-effectiveness
model shows that choosing to observe patients with clinical complete response is
both cheaper and more effective than surgical intervention for this unique patient
population.
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OBJECTIVES: To evaluate the prognostic factos of secondary hip replacement fol-
lowing the primary reduction internal screw fixation of femoral neck fractures.
METHODS: In this retrospective study the data derive from the database of the
Hungarian National Health Insurance Fund Administration. The study includes
patients over 60 years following primary reduction internal screw fixation of fem-
oral neck fracture (S7200) discharged from inpatient care institutions in 2000. Dur-
ing the 8 years follow up period the data of secondary hip replacement were re-
corded. We evaluated the following risk factors: age, sex (male/female), type of
primary femoral neck fracture (extracapsular, intracapsular undisplaced/intraca-
psular displaced), the season of primary treatment (spring, summer, autumn/win-
ter), day of surgery (week-day/weekend), surgical delay (6-12h, 12-24h, 24h/ 0-6h)
and the absence or presence of comorbidities. The effects of prognostic factors
were evaluated by Cox proportional hazard regression analysis (HR, 95 % CI, p).
RESULTS: A total of 2784 patients with primary reduction internal screw fixation
met the inclusion criteria. In the follow up period 6.82 % (190 cases) of patients
underwent secondary hip replacement, mainly due to osteonecrosis, nonunion
and coxarthrosis. Significant correlation can be shown between suffering second-
ary hip replacement and the age (year, HR0.968, CI:0.951-0.986), the type of frac-
ture (intracapsular undisplaced vs. displaced, HR0.395, CI:0.260-0.601) and the
season of primary surgical intervention (fall vs. winter, HR0.505, CI:0.336-0.760
spring vs. winter, HR0.626, CI:0.429-0.914 summer vs. winter, HR0.613,
CI:0.415-0.906). CONCLUSIONS: The role of age and fracture displacement are well-
known as a risk factors in a literature, but the impact of winter season of primary
osteosynthesis is unknown. In the future this result should be further investigated
in the context of seasonal changes in vitamin D level and bone remodeling, focus-
ing on decreasing the secondary treatment with high burden after femoral neck
fractures with reduction internal fixation.
SURGERY - Cost Studies
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BUDGET IMPACT ANALYSIS OF ANTI-BACTERIAL SUTURE USE IN
APPENDECTOMY PROCEDURES IN SPAIN
Pobre MA1, Espallardo O2
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OBJECTIVES: Surgical Site Infection (SSIs) is the most frequent type of hospital-
acquired infection, accounting for more than (37%). The prevalence of hospital-
acquired infection in Spain is 7.8%, where SSI account for 19%. For appendectomy
procedures, the SSI rate of 4.9% is reported. SSI increases the patient’s risk of
morbidity and mortality, prolongs hospital stay by more than a week, and worsens
the overall patient quality of life. Moreover, the risk of SSI has increased recently
due to multiple comorbidities. In addition, SSI is becoming more treatment-resis-
tant than ever. The aim of this study was to analyze the economic consequences of
using antibacterial sutures in appendectomy procedures in Spain. METHODS: A
dynamic excel-based decision-analytic model was developed. Published literature
reviews were used to estimate the three key variables: SSI reduction using antibac-
terial sutures (55%7) compared to standard sutured, prolonged length of hospital
stay due to SSI (7.7 days), and the cost of hospital stay per day (2,057€). The rate of
readmission due to persistent infection was used (18%), which was estimated as
costs 2,166€, and it was added to the prior amount to calculate total costs of infec-
tion. Country input data for the model were reported as the number of appendec-
tomy procedures performed per year (34,500). The list price at which regular and
antibacterial sutures were purchased was also collected. A two-way sensitivity
analysis was conducted, with two variables being the infection rate and suture
price. RESULTS: Antibacterial sutures were found to be 14% more expensive; how-
ever, allowing a 56% of hospital cost avoidance. This may have an impact of
4,970,273€ in annual savings in Spain. CONCLUSIONS: This analysis presents new
evidence of support of the use of antibacterial sutures by demonstrating that it
could reduce the SSI rate, and could allow cost-savings compared to standard
sutures, among other benefits.
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ORTHOBIOLOGIC BONE GRAFT SUBSTITUTE IN FOOT AND ANKLE FUSION
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OBJECTIVES: No multicenter studies currently assess the incremental costs of au-
togenous bone graft harvest (autograft) in foot and ankle procedures. This study
applied conservatively estimated incremental costs of autograft (with and without
bone graft supplements/enhancers) using an interactive budgetary impact model
comparing costs and cost offsets of an orthobiologic bone graft substitute (-TCP
with recombinant human platelet-derived growth factor-BB [rhPDGF-BB]) in foot
and ankle fusion procedures. METHODS: A Canadian hospital-based budget im-
pact model was developed utilizing International Society of Pharmacoeconomics
and Outcomes Research (ISPOR) guidelines. Clinical and health economic litera-
ture, data from a 434-patient randomized control trial and data from a panel of ten
experienced orthopaedic surgeons provided estimates of medical resource utiliza-
tion and associated hospital costs. Model parameters were confirmed by six indi-
viduals representing 15 Canadian hospitals. RESULTS:Autograft carries incremen-
tal costs related to operating suite time (37.9 17.0 minutes for an iliac crest donor
site and 22.1  21.6 minutes for local donor sites), recovery room time (25.0  12.3
minutes for iliac and 3.5  9.4 minutes for local), and donor site complications.
Conservative base case incremental costs were $1,601(CAD) for iliac crest and $755
(CAD) for local sites. Complications at the harvest site contributed an additional
base case cost of $414 for iliac crest and $182 for local sites. Use of an orthobiologic
bone graft substitute had higher acquisition costs, but yielded per-case and annu-
alized cost savings ($34 and $2,454, respectively, base case) by eliminating incre-
mental costs, graft harvest complications, and patient pain reported for autograft
harvest during clinical trial. CONCLUSIONS: The gold standard of harvesting au-
togenous bone graft as an adjunct to foot and ankle fusion surgery is associated
with significant health care costs. The use of -TCP with rhPDGF-BB eliminated
variable, incremental hospital costs associated with bone graft harvesting and
treating related complications.
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COSTS OF CARDIOVASCULAR READMISSIONS FOLLOWING PERCUTANEOUS
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DATA FROM A LARGE MULTI-CENTRE AUSTRALIAN REGISTRY
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OBJECTIVES: Chronic kidney disease (CKD) and end-stage kidney disease are well-
established risk factors for early mortality and morbididy in patients with coronary
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artery disease. However, there is limited data on the subsequent hospitalizatons
and related direct health care costs among patients with pre-existing CKD under-
going percutaneous coronary intervention (PCI). We aimed to compare the rates
and costs of cardiac-related hospital readmissions following PCI in patients with
and without pre-existing CKD. METHODS: Direct health care costs were estimated
from 12,998 patients enrolled in the Melbourne Interventional Group (MIG) registry,
who underwent PCI between April 2004 and October 2010. Only individuals with
data on cardiovascular-related hospitalizations and medication use at 12-month
follow-up were included. Individual patient-procedures were assigned unit costs
based on published (DRG) data from the National Hospital Cost Data Collection for
Admissions in Victoria, Australia (2008-2009) and the Australian Pharmaceutical
Benefit Scheme schedule (2011-2012). A ‘bottom-up’ costing approach was used.
Costs relating to the index procedure and in-hospital complications were excluded.
Bootstrap linear regression was used to estimate the association between direct
medical costs and CKD categories, adjusting for age, gender and relevant
comorbidities. RESULTS: Excess cardiac-related readmissions occurred among pa-
tients with estimated glomerular filtration rate (eGFR)30 ml/min/1.73m2 (“severe
CKD or dialysis”, N330; 35%), compared to eGFR: 30-60 ml/min/1.73m2 (“moderate
CKD”, N2,648; 28%) or patients with eGFR60 ml/min/1.73m2(“referent group”,
N10,020; 24%). Adjusted mean (95%CI) total follow-up costs were significantly
higher in patients with severe CKD or dialysis [$AUD 2,206 ($AUD 1,148 - 3,688)].
CONCLUSIONS: Patients with severe CKD/dialysis undergoing PCI procedures in-
curred the highest mean direct health care costs at 12-month follow-up, compared
to those with better renal function. Hospitalization accounted for the majority of
these expenditures. Data gathered from this study have the potential to inform
policy makers of the likely economic impact of CKD in the context of invasive
treatment of CAD.
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OBJECTIVES: Surgery is common after a hip fracture. Two surgical options are
arthoplasty (AR) (i.e., hip replacement) or internal fixation (IF) (i.e., fixing the pa-
tient’s hip). Previous research suggests that AR is less costly than IF because IF
failure rate is high. This retrospective cohort study compared medical costs be-
tween IF and AR in patients with hip fractures of the femoral neck in a large US
population.METHODS: Patients50 years with IF or AR performed within 7 days of
a hip femoral neck fracture occurring between 7/1/2002 and 1/31/2010 were iden-
tified from the Marketscan database. Details on the specific location of the fracture
line within the femoral neck were not available. All patients had continuous insur-
ance coverage for 6 months prior to (pre-period) and 60 days following (post-period)
the surgery date (index date). Patients were followed from surgery date up to 18
months or until death, end of continuous enrollment, or end of study period (3/31/
2010), whichever came first. Generalized linear models on costs were used to adjust
different patient demographic and clinical characteristics. RESULTS: A total of
41,789 patients (mean age 80 years) were identified (60% IF and 40% AR patients).
Post-period mean monthly costs were similar between the two cohorts ($4344 for IF
vs. $4401 for AR, p0.339). Costs were the highest in the first month when the
surgery occurred and the IF cohort had lower cost than the AR cohort ($22,707 vs.
$25,646, p0.001). No statistically significant differences were found in the multi-
variate adjusted total mean monthly costs. The AR cohort had slightly higher in-
patient costs ($2642 for AR vs. $2469 for IF, p0.001) but lower outpatient costs
($1463 for AR vs. $1653 for IF, p0.001). CONCLUSIONS: In this large population,
both IF and AR interventions result in significant and similar health care costs.
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OBJECTIVES: Minimally Invasive Spinal Surgery (MIS) aim at minimizing muscle
trauma, reducing blood loss, decreasing postoperative pain, reducing surgery du-
ration and length of stay in hospital (LoS), and accelerate resuming normal activi-
ties for the patient. The objective of this study is to determine and compare the
resource consumption associated with OS vs. MIS in patients with degenerative
spinal disorder treated with a short construct. METHODS: This study was realized
in two French hospitals: one public and one private hospital, in which the learning
curve could be considered completed. To map the patient flow and estimate re-
source utilization, the clinical pathways of patients treated with open and MIS
spinal instrumentation were defined through interviews with medical staff. The
2009 French Hospitalization Costs Database (ENCC) updated with 2012 DRG tariffs,
was used to estimate the unit costs where differences were significant: 1) operating
room (OR), 2) LoS, 3) blood consumption. Costs were compared between both path-
ways (OS vs. MIS), in order to calculate the mean difference of costs. RESULTS: In
both hospitals MIS was associated with less resource use especially during surgery
and post-surgery episodes. This is mainly due to shorter OR time, LoS and less
blood loss. In the public case, 40% decrease in surgery time was observed, 38%
reduction in LoS and 100% decrease in blood consumption. In the private hospital,
28% decrease in surgery time, 41% reduction in LoS and 100% decrease in blood
consumption. The mean total costs saving associated with MIS corresponds to
1,469€ in the public hospital; and 652€ in the private hospital. CONCLUSIONS: MIS
potentially shortens operating and recovery time, decreases blood consumption,
and consequently reduces direct medical costs of hospital stays. This reduction
may offset the upfront investment (e.g. instrumentation). The findings are consis-
tent with published literature.
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SURVIVAL AND COST COMPARISON OF BALLOON-KYPHOPLASTY AND
VERTEBROPLASTY USING GERMAN CLAIMS DATA
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OBJECTIVES: Osteoporotic vertebral compression fractures (OVCFs) are associated
with increased morbidity and mortality and with reduction in QoL. Vertebral aug-
mentation has been shown to be effective for treating these fractures. The associ-
ation between treatment and survivorship was analyzed in the Medicare Popula-
tion (Edidin 2010). Moreover, cost comparisons of kyphoplasty (BKP) and
vertebroplasty (VP) suggest that initial hospital costs are higher for BKP (Mehio
2011), while another study has reported cost effectiveness of BKP compared to VP
(Edidin 2012) Extensions of these analyses are necessary to verify the results for the
German setting. The purpose of the present study was to examine the overall
survival and treatment costs from a third payer perspective for OVCF patients
treated by VP or BKP. METHODS: To address the research questions claims, data of
a major health insurance fund (2.4 million insurants in 2011) were used. Groups
were established by propensity score matching adjusting for gender, age and over-
all comorbidity. For the matched OVCF-patients in the dataset (2006-2010) costs
were analyzed as well as survival was estimated by the Kaplan-Meier method.
RESULTS: A total of 598 newly diagnosed OVCF-patients who underwent vertebral
augmentation were identified from the data. After adjustment, 298 patients re-
mained. BKP-patients had a higher 60-month adjusted survival rate of 66.7%, com-
pared to 58.7% for VP-patients (p0.68). Cumulative 4-year mean overall costs
following the first diagnosis were lower for the BKP-cohort (VP: 42,510€ vs. BKP:
39,014€). Initially higher costs were mainly driven by costs for surgical treatment.
However, considerable pharmacy costs in VP-patients outweighed the primordially
lower inpatient costs. Major differences were found in costs for pain killers. (ATC
N02; VP: 3,321€ vs. BKP: 2,224€). CONCLUSIONS: Results suggest higher overall
survival for BKP-patients compared to VP-patients. Total costs were found to be
lower after 4 years for patients who received BKP due to lower pharmacy costs in
the long run.
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ECONOMIC IMPACT OF SCOLIOSIS IN CANADA: A RAMQ DATABASE ANALYSIS
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OBJECTIVES: Scoliosis is defined as a lateral deviation of the spine. Although most
of the curves are small to moderate and never necessitate intervention, some of
these curves progress and will require surgical interventions. These procedures are
associated with significant health care resources consumption. The objective of
this study was to assess the economic impact of scoliosis from a Canadian health
care system perspective. METHODS: Using a subset of 125,000 patients covered by
the provincial drug reimbursement program (Régie de l’assurance maladie du Qué-
bec (RAMQ)), a retrospective prescription and medical claims analysis was per-
formed. Patients who received a diagnosis of scoliosis (ICD9  737.3) from January
2003 to December 2011 were included in the analysis. Annual health care resources
utilization and costs were estimated for patients with scoliosis. Surgical proce-
dures associated with scoliosis were identified using the procedure codes found in
the RAMQ database. The costs and the resources utilization associated with the
surgical procedures were estimated over a one-year period from 30 days preceding
to 335 days following the surgery. RESULTS: Between January 2003 and December
2011, 523 individuals of the sample population received a diagnosis of scoliosis,
with a higher proportion of females (70.6%). Among these patients, 22 (4.2%) re-
quired at least one scoliosis surgery, for a total of 94 procedures. Most surgeries
were correction of the scoliosis via a posterior approach using Luke or Cotrel-
Dubousset segmental instrumentation (84% of all the procedures). The mean an-
nual medical cost associated with scoliosis was $4,865 while it was $29,777 for
patients who had a surgery. Annual medication cost were $1,178 for all patients
with scoliosis and $1,546 for patients who had a surgery. CONCLUSIONS: The eco-
nomic impact of scoliosis in Canada is substantial, especially when a surgical in-
tervention is required.
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CLINICAL AND ECONOMIC BURDEN OF ANASTOMOTIC LEAKS AFTER
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OBJECTIVES: Anastomotic leaks after colorectal surgeries can lead to complica-
tions, and considerably increase medical resource use and cost. This study quan-
tified the incidence, and clinical and economic burden of anastomotic leaks follow-
ing colorectal surgeries in the US. METHODS: Premier Perspective database was
used to identify patients having a set of colorectal surgeries between Jan 2008 to
Dec 2010. The colorectal surgeries included colectomy, hemicolectomy, and rec-
tum resection. The anastomotic leak event was defined by re-operation, re-anas-
tomosis, stent, colostomy, drainage, and abscess within 30-day window following
the index colorectal surgeries. The index surgery and re-intervention were identi-
fied by ICD-9 procedure codes, CPT codes and Standard Charge Master codes. This
study entails two analyses: (1) the overall incidence rate of 30-day anastomotic
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